Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discovery

31 Jul 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Drug Discovery Methods
Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32837137
DOI: 10.1007/s00044-020-02610-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discoveryPMID 32837137Read ↗

Potential drug targets of SARS-CoV-2: From genomics to therapeuticsSemantic proximity Read ↗

An Overview of SARS-CoV-2 Potential Targets, Inhibitors, and Computational Insights to Enrich the Promising Treatment StrategiesSemantic proximity Read ↗

Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19Semantic proximity Read ↗

Recognition of plausible therapeutic agents to combat COVID-19: An omics data based combined approachSemantic proximity Read ↗

Decoding Covid-19 with the SARS-CoV-2 GenomeSemantic proximity Read ↗

Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approachSemantic proximity Read ↗

Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19Semantic proximity Read ↗

Translating GWAS Findings to Inform Drug Repositioning Strategies for COVID-19 TreatmentSemantic proximity Read ↗

Molecular characterization, pathogen-host interaction pathway and in silico approaches for vaccine design against COVID-19Semantic proximity Read ↗

'Geno-to-pheno' SARS-CoV-2 genome-COVID-19 association studies.Semantic proximity Read ↗

Drug-repurposing against COVID-19 by targeting a key signaling pathway: An in silico studySemantic proximity Read ↗

An overview of basic molecular biology of SARS-CoV-2 and current COVID-19 prevention strategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.